Initially, patients aged 60 years and above or those with co-morbidities like asthma and diabetes, and health workers will receive the vaccines. Credit: Sam Moqadam on Unsplash.

Colombia’s National Institute of Drug and Food Surveillance (INVIMA) has authorised emergency use of Pfizer and BioNTech’s Covid-19 vaccine.

Reuters quoted Colombian President Ivan Duque as saying in a broadcast that this is a very important step.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Columbia now awaits approval for Covid-19 vaccines of AstraZeneca and Janssen, the pharmaceutical unit of Johnson & Johnson.

In the initial stage, patients aged 60 years and above or those with co-morbidities such as asthma and diabetes, and health workers will receive the vaccines.

Earlier, Colombia signed a deal to procure ten million doses each of the Pfizer-BioNTech and AstraZeneca vaccines and nine million vaccine doses from Janssen.

Furthermore, through the World Health Organisation (WHO)-backed COVAX programme, the country secured 20 million vaccine doses.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Colombia minister of health stated that the country should receive its first batch of 1.7 million doses of Pfizer-BioNTech vaccine in February, with inoculation initiated simultaneously.

The news agency quoted the WHO as saying that individuals should receive two doses of the Pfizer-BioNTech vaccine within 21-28 days.

In a separate development, Mexico’s health regulator Cofepris and Bangladesh also approved the Oxford University and AstraZeneca’s Covid-19 vaccine.

Mexican Foreign Minister Marcelo Ebrard said on Twitter: “The emergency approval of the AstraZeneca vaccine by Cofepris is very good news. With this, production will start soon in Mexico.”

Last month, Bangladesh Health Ministry, Beximco Pharma and Serum Institute of India (SII) entered into an agreement to procure 30 million doses of the vaccine, Anadolu Agency reported.

The Directorate General of Drug Administration permitted Beximco to obtain the doses from SII, which is manufacturing the vaccine.

Last month, the UK Medicines and Healthcare products Regulatory Agency (MHRA) granted authorisation for emergency supply to AstraZeneca’s Covid-19 vaccine in the country.